IFI-P · Thymol Series

Specimen SS-F-TRP-535 // PUNGENT · IFI-P

Thymol Series II-IV-A

Thymus vulgaris

Thyme

Tier IIThymol Series

Target Trait

1.92×

fold-change

Thymol TRPA1 agonist fold-change

Technical Specifications

SKU

SS-F-TRP-535

Genomic Edits

4

GC Content

47.3%

Construct Length

2,877 bp

Promoter System

T7/SP6 cell-free

Expression System

In-vitro cell-free

Host Strain

Cell-free

Receptor Target

TRPA1

IFI Score

192

Pathway Edits

  • CYP71D180 (thymol synthase cytochrome P450) overexpression for gamma-terpinene hydroxylation to thymol in Thymus vulgaris
  • Thymol synthase regulatory element engineering for constitutive CYP71D180 expression independent of developmental stage
  • G10H (geraniol 10-hydroxylase) upregulation for monoterpene precursor geranyl diphosphate pool expansion
  • GPP synthase (geranyl pyrophosphate synthase) overexpression for thymol C10-skeleton precursor biosynthesis

Key Interventions

CYP71D180/G10H cascade amplification for high-yield thymol accumulation in Thymus vulgaris via gamma-terpinene substrate channelingGPP synthase overexpression expands the C10-monoterpene precursor pool feeding the dedicated thymol biosynthesis branch with minimal carvacrol co-formationThymol TRPA1 agonism at the electrophilic binding site confirmed by IFI-P calcium-flux assay; characteristic herbal-pungent medicinal peppery sensation validated in panel cohortCell-free T7/SP6 translation system for in-vitro pungency pathway enzyme validation

IFI Subscale Profile

IFI Profile

IFI-S
—
IFI-U
—
IFI-B
—
IFI-K
—
IFI-C
—
IFI-P
192
IFI-A
—
IFI-F
—

Use Case

Tier II thymol-enriched Thymus platform for precision herbal flavor ingredient production, TRPA1-selective warming pungency in culinary herbs, medicinal-flavor functional food applications, and standardized thymol supply for antimicrobial flavor systems where natural source variability introduces inconsistent sensory profiles in oregano-thyme spice blends and Mediterranean flavor applications.

License

$699 · Tier II License

Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.

Already purchased?

Back to Pungent · IFI-PAll Modalities